These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8502688)

  • 1. Delta hepatitis and infection in North America.
    Alter MJ; Hadler SC
    Prog Clin Biol Res; 1993; 382():243-50. PubMed ID: 8502688
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis D virus and other chronic viral infections in high risk populations: interaction from an epidemiologic perspective.
    Stevens CE
    Prog Clin Biol Res; 1991; 364():361-4. PubMed ID: 1902297
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroprevalence of HDV and HIV in two populations at risk for infection with HBV in Spain.
    Herrera A; Ortega E; Soler JJ; García S; Rodriguez C; Del Romero J
    Prog Clin Biol Res; 1993; 382():267-75. PubMed ID: 8502691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of hepatitis delta infection in Italy over the last 18 years.
    Sagnelli E; Stroffolini T; Ascione A; Bonino F; Chiaramonte M; Colombo M; Craxì A; Manghisi OG; Pasquale G; Pastore G
    Prog Clin Biol Res; 1993; 382():287-94. PubMed ID: 8502693
    [No Abstract]   [Full Text] [Related]  

  • 5. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece.
    Hadziyannis SJ; Dourakis SP; Papaioannou C; Alexopoulou A; Hadziyannis ES; Gioustozi A
    Prog Clin Biol Res; 1993; 382():259-66. PubMed ID: 8502690
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of human immunodeficiency virus infection on acute and chronic HBsAg-positive hepatitis.
    Caredda F; Antinori S; Coppin P; Parravicini C; Vago L; Moroni M
    Prog Clin Biol Res; 1991; 364():365-75. PubMed ID: 2020711
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute delta hepatitis in Greek parenteral drug abusers.
    Tassopoulos NC; Koutelou MG; Papatheodoridis GV; Kalantzakis YS; Hatzakis AE
    Prog Clin Biol Res; 1993; 382():221-7. PubMed ID: 8502685
    [No Abstract]   [Full Text] [Related]  

  • 8. Human immunodeficiency virus and viral hepatitis seroepidemiology in New York City intravenous drug abusers (IVDAs).
    Brown LS; Kreek MJ; Trepo C; Chu A; Banks SE; Valdes M; Ajuluchukwu D; Phillips R; Primm BJ
    NIDA Res Monogr; 1989; 95():443-4. PubMed ID: 2641023
    [No Abstract]   [Full Text] [Related]  

  • 9. Delta hepatitis in the Americas: an overview.
    Maynard JE; Hadler SC; Fields HA
    Prog Clin Biol Res; 1987; 234():493-505. PubMed ID: 3306706
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple viral infections.
    Gaeta GB; Precone DF; Cozzi-Lepri A; Cicconi P; D'Arminio Monforte A
    J Hepatol; 2006; 44(1 Suppl):S108-13. PubMed ID: 16352369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis delta in South America and especially in the Amazon region.
    Gayotto LC
    Prog Clin Biol Res; 1991; 364():123-35. PubMed ID: 2020689
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B and delta hepatitis infection in Peru.
    Sjogren MH; Colichon A
    Prog Clin Biol Res; 1991; 364():97-104. PubMed ID: 2020727
    [No Abstract]   [Full Text] [Related]  

  • 14. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta hepatitis in North Carolina: learning from a patient.
    Drucker JL; Jacob DJ; Hamilton JD
    N C Med J; 1986 Jul; 47(7):339-40. PubMed ID: 3461289
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N; Arora U; Singh K
    Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hepatitis due to HBV-HDV coinfection.
    Zar T; Sharar Z; Mughal M; McClintock C
    Conn Med; 2001 Nov; 65(11):649-52. PubMed ID: 11766551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing prevalence of hepatitis B virus and hepatitis D virus infection among injecting drug users in Hong Kong indicating a change in high-risk behaviour.
    Lim WL; Lo JY; Lee SH
    AIDS; 1995 Sep; 9(9):1110-2. PubMed ID: 8527093
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis delta virus super-infection in a co-infected patient with the human immunodeficiency virus type 1 and a surface antigen-negative hepatitis B virus variant.
    Gordien E; Bouhassoune K; Calboreanu A; Alloui C; Rico-Garcia M; Salmon-Céron D; Legal F; Dény P; Sogni P; Podevin P
    Int J STD AIDS; 2006 Sep; 17(9):635-8. PubMed ID: 16942658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.